CClinicalTrials.gg
CompletedNCT03320122STARSUpdated Nov 18, 2023

School-Based Tele-Physiatry Assistance for Rehabilitative and Therapeutic Services

An interventional study of Telemedicine and In-Person Pediatric Physiatrist in Pediatrics, Physical and Rehabilitation Medicine and Physical Therapy Modalities, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged Up to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by University of California, Davis · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
Up to 21 Years
Sex
All
01

Study summary

Using a randomized trial design, the goal of this project is to prospectively compare outcomes from a telemedicine-based model of care to two cohorts: patients who receive in-person pediatric physiatrist medical direction (the "gold standard"), and those who receive medical oversight from non-specialist community providers. This project will determine the impact of this new model of care using telemedicine on parent/guardian satisfaction, adherence rates to an evidence-based hip surveillance program, and economic efficiency.

Read the detailed description

During this study, a novel model of care will be developed and tested using telehealth technologies to bring necessary medical expertise to children with special health care needs living in rural and underserved communities. This model of care will be implemented in eight school-based Medical Therapy Units (MTUs) in northern California using a randomized design. The investigators hypothesize that this model of care will result in 1) equal satisfaction of the care received in-person from pediatric physiatrists and increased satisfaction of the care received from non-pediatric specialists; 2) equal adherence rates to an evidence-based hip surveillance program when compared to children who receive care from in-person pediatric physiatry care and better adherence than children who receive care from non-pediatric specialists; and 3) cost savings when compared to medical direction provided in-person by pediatric physiatrists and non-pediatric specialist providers.

The first 6 months of the project will be a "ramp-up" period during which the protocol will be re-reviewed during MTU site visits and necessary contracts and approvals will be in place. The last 6 months will be reserved for data analysis, study closeout, and manuscript preparation. The intervention phase will include various designs of implementation. For those schools currently without pediatric physiatry services, the investigators will provide MTU services using telemedicine and add in-person clinics. For those schools where medical direction is provided by non-pediatric physiatrists, the investigators will augment current services using telemedicine to provide medical direction to some children using pediatric physiatrists. For those schools where pediatric physiatrists travel long distances to provide medical direction during scheduled clinics, the investigators will similarly add additional telemedicine services such that an augmented mixed model of in-person and telemedicine pediatric physiatrist medical direction will be provided.

02

Conditions studied

  • Pediatrics
  • Physical and Rehabilitation Medicine
  • Physical Therapy Modalities

Keywords

  • Telemedicine
03

Who can participate

Ages eligible
Up to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants will include children with special health care needs enrolled in the CCS Medical Therapy Program receiving care at one of the participating sites during the study period.

Exclusion criteria

Exclusion Criteria:

  • Children with special health care needs not enrolled in the CCS Medical Therapy Program.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
350 participants (actual)

Study arms

  • Experimental
    Telemedicine

    Medical Direction will be provided by pediatric physiatrists using telemedicine.

    Other: Telemedicine

  • Active comparator
    In-Person Pediatric Physiatrist

    Medical Direction will be provided by pediatric physiatrists in-person.

    Other: In-Person Pediatric Physiatrist

  • Active comparator
    In-Person Non-Pediatric Physiatrist

    Medical Direction will be provided by contracted physicians (i.e., non-pediatric physiatrists) in-person care.

    Other: In-Person Non-Pediatric Physiatrist

Interventions

  • OtherTelemedicine

    Medical direction will be provided to MTUs through a video-based conferencing unit. Each telemedicine unit includes a Rubbermaid medical grade cart with a Polycom RealPresence 500 Series high-resolution video-conferencing unit flat screen to display video. Each cart also comes with an Uninterrupted Power Supply (UPS) to make the unit mobile if needed or to properly shut it down in the event of power failure.

  • OtherIn-Person Pediatric Physiatrist

    UC Davis pediatric physiatrists will drive out to the school-based MTUs to provide medical direction in person.

  • OtherIn-Person Non-Pediatric Physiatrist

    A contracted physician (i.e., a non pediatric physiatrist) would provide medical direction in person.

05

What researchers measure

Primary outcomes

  1. Parent/Guardian Satisfaction Survey

    The effect of providing pediatric physiatrist medical direction across groups will be measured through satisfaction surveys that will be distributed to participating parents and guardians. Satisfaction surveys will utilize a seven-point Likert scale and the investigators will assess the inter-item reliability, dimensionality and construct validity of satisfaction scales using standard multivariable analysis techniques. A higher score represents a higher satisfaction rate. The investigators postulate that a minimally important clinically significant difference is approximately 0.50 points, while a difference of 0.30 is tolerably close for purposes of non-inferiority.

    Time frame: Over 1 day for each patient

  2. Evidence-Based Hip Surveillance Program Survey

    The hip surveillance survey utilizes several Yes/No responses to compare guideline adherence between the three cohorts and the questions are directly linked to the clinical expectations and explicit guidelines for the appropriate timing and frequency of x-rays and exams. Adherence rates will be compared by adjusted odds ratios.

    Time frame: Over 1 day for each patient

  3. European Quality of Life-5 Dimensions (EQ-5D) Survey

    The EQ-5D is a quality of life assessment tool for measuring "utility." The "utility" is a comprehensive health measure, ranging from 0 (death) to 1 (perfect health), based on an individual's health state in five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The utility for a certain health condition is calculated by applying an established formula that assigns weights to each of the levels in each dimension determined by this health condition. These data on a quality of life will be used in a cost-effectiveness analysis.

    Time frame: Over 1 day for each patient

  4. Economic Efficiency

    Cost analysis will estimate cost changes resulting from the introduction of this new model of care from the perspectives of patients and families, physicians and healthcare providers, and payers. The proposed economic evaluative methods will integrate all of the effectiveness results from patient encounter data and EQ-5D survey data. Cost analysis will estimate return-on-investment indicating the cost-saving amount per $1 investment in telemedicine compared to MTUs without telemedicine.

    Time frame: Up to 4 years

06

Study locations

1 site
  • University of California, Davis, Medical Center
    Sacramento, California 95817, United States
07

References and documents

08

Registry details

Key details

Study ID
NCT03320122
Lead sponsor
University of California, Davis
Responsible party
Sponsor
First posted
Oct 25, 2017
Start date
Feb 1, 2017
Primary completion
Jul 31, 2023
Completion
Jul 31, 2023
Last update
Nov 18, 2023

Study contacts

James Marcin, MD, MPH
principal investigator · UC Davis Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion